Mounjaro Price Australia 2026: Monthly Cost, Dose Prices & Cheapest Providers
Mounjaro (tirzepatide) costs A$285–A$690 per month privately in Australia depending on dose. This page sets out the dose-by-dose monthly price, the cheapest pharmacy and telehealth provider routes, the PBS position, and how Mounjaro compares with Wegovy and Ozempic on cost.
Mounjaro is not currently PBS-listed for weight management, so patients pay the full private price. Quoted figures are medicine-only — consultation, delivery and programme fees apply on top depending on the route.
How much does Mounjaro cost in Australia per month in 2026?
Australia Weight-loss comparison
Compare weight-loss injection prices before you choose a provider
Move from article research into current provider prices, medicine-by-medicine costs and programme routes.
Important context
Healthcare prices can change without notice and may exclude consultation fees, medication, diagnostics, anaesthetic, facility fees, follow-up care or add-ons. TreatCompare summarises published or compiled pricing for comparison and planning only. Always verify the current total directly before paying.
- Source type
- Provider-published prices and Australian regulatory sources
- Primary source
- Compounding pharmacies, telehealth providers and PBS / TGA published information
- Reporting period
- May 2026
- Last updated
- May 2026
- Figure type
- Mixed sources
- Use
- Research and comparison only
Are you a clinic, provider or data owner?
If you believe information on this page is inaccurate, out of date, incomplete or presented without necessary context, contact us with the page URL and supporting evidence. We review correction requests promptly, but they are not automatically accepted.
Monthly cost summary
Mounjaro is priced per four-week pen in Australia and the dose increases over the first months of treatment. Most patients start at A$285/month for the 2.5mg titration dose and end up paying somewhere between A$425/month (5mg) and A$690/month (15mg) once they reach a maintenance dose. The cheapest medicine-only route is generally compounding pharmacies that dispense against a private script from a GP or telehealth doctor.
Starter
A$285
2.5mg / month
Typical maintenance
A$550
10mg / month
Maximum dose
A$690
15mg / month
Dose-by-dose price table (Australia, 2026)
| Dose | Typical monthly cost | Access route | Notes |
|---|---|---|---|
| 2.5mg (starter) | from A$285/month | Private prescription | Four-week titration dose for month one before stepping up. |
| 5mg | around A$425/month | Private prescription | First escalation dose. Some patients maintain here long term. |
| 7.5mg | around A$485/month | Private prescription | Intermediate dose used during further titration. |
| 10mg | around A$550/month | Private prescription | Common maintenance dose. Often the cheapest dose at which weight-loss results plateau favourably. |
| 12.5mg | around A$620/month | Private prescription | Intermediate higher dose if 10mg is insufficient. |
| 15mg (maximum) | around A$690/month | Private prescription | Maximum licensed dose. Highest published weight-loss results in SURMOUNT trials. |
Prices are indicative private monthly costs for the medicine itself, drawn from published compounding pharmacy and telehealth provider pages. Final cost depends on pharmacy, supply, stock and whether consultation fees apply.
Cheapest provider routes
| Provider route | From | Pricing model | What is included |
|---|---|---|---|
| Compounding pharmacy direct | A$285+/month | Script-only | Medicine only. You provide the script from a GP or telehealth doctor. |
| Telehealth programme (Juniper) | A$349+/month | Programme bundle | Medicine, online consultation, dose adjustments, programme support. Women-focused. |
| Telehealth programme (Pilot) | A$349+/month | Programme bundle | Medicine, online consultation, follow-up reviews, support. Men-focused. |
| Telehealth programme (Mosh) | Confirmed after assessment | Programme bundle | Medicine, consult, support. Broader telehealth audience. |
Cheapest by headline price is rarely cheapest overall — a script-only pharmacy looks cheaper than a programme but you still pay for a GP or telehealth consultation to obtain the script. For an apples-to-apples view, see the cheapest weight-loss injections in Australia page.
Consultation, script, shipping and pharmacy fees
- Initial consultation: A$50–A$120 via telehealth, sometimes free as part of a bundled programme.
- Follow-up consultations: A$30–A$80 every few months for dose review.
- Shipping / delivery: A$0–A$20 depending on provider. Cold-chain delivery is standard for tirzepatide.
- Pharmacy dispensing fee: Already included in published medicine prices in most cases.
- Blood tests or GP review: Variable — may be required at start and during dose changes.
- Cancellation terms: Programme providers often run month-to-month subscriptions. Check the cancellation route before paying.
Mounjaro vs Wegovy vs Ozempic cost comparison (Australia)
| Mounjaro | Wegovy | Ozempic | |
|---|---|---|---|
| Starter dose price | A$285/month (2.5mg) | A$269/month (0.25mg) | A$130–A$200/pen private |
| Maintenance price | A$550–A$690/month | A$350–A$390/month | A$130–A$200/pen private |
| Mechanism | Dual GIP/GLP-1 | GLP-1 | GLP-1 |
| PBS for weight loss | No | No | No (PBS only for type 2 diabetes) |
| Average trial weight loss | 15–22.5% body weight (SURMOUNT) | 12–15% body weight (STEP) | Not licensed for weight loss |
| Manufacturer | Eli Lilly | Novo Nordisk | Novo Nordisk |
Full side-by-side write-up: Mounjaro vs Wegovy in Australia. Ozempic is only PBS-listed for type 2 diabetes — off-label use for weight loss is restricted and supply has been limited in recent years.
What is the typical Mounjaro maintenance dose?
Mounjaro is titrated upward over several months. Most patients begin at 2.5mg for one month, escalate to 5mg, and continue stepping up every four weeks unless a dose is well tolerated and effective.
Common maintenance doses sit at 10mg or 15mg. In the SURMOUNT-1 trial, the 15mg dose produced an average 22.5% body-weight reduction over 72 weeks; the 10mg dose averaged 19.5%. The right maintenance dose is a clinical decision based on response and side-effects — not a budget decision — but the cost difference between 10mg and 15mg (~A$140/month) is worth knowing in advance.
Prescription-only medicine
Mounjaro (tirzepatide) is a prescription-only medicine in Australia (Schedule 4). It must be prescribed by an AHPRA-registered medical practitioner after clinical assessment of suitability. Mounjaro is not appropriate for everyone and is contraindicated in some conditions (including a personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia type 2). TreatCompare publishes price data only — clinical suitability is determined by your prescriber. Always disclose your full medical history at consultation and report side-effects to the TGA via TGA safety reporting.
Frequently asked questions
How much is Mounjaro in Australia per month in 2026?
What is the cheapest Mounjaro dose in Australia?
What is the cheapest Mounjaro 10mg price in Australia?
Is Mounjaro on the PBS in Australia?
Is Mounjaro or Wegovy cheaper in Australia?
What is the cheapest GLP-1 in Australia?
Related Australian weight-loss pages
Sources & further reading
- PBS medicine search — PBS listing and subsidy status for medicines in Australia.
- TGA medicine information — Australian medicine regulatory information and safety context.
- AHPRA Register of Practitioners — Registration checks for Australian prescribers.
- NICE TA1026 — Tirzepatide for weight management — Clinical evidence base for tirzepatide weight management efficacy.
- Provider websites — Published provider prices and programme inclusions collected by TreatCompare.
How we collect Australian Mounjaro prices
Prices are taken from published compounding pharmacy pages, telehealth provider price pages and our own scraped provider data. We separate medicine-only quotes from programme-bundled quotes so the comparison is fair. Prices change with stock, dose and pharmacy contract — confirm your written quote at consultation. TreatCompare publishes data, not clinical advice. No provider pays for inclusion or for framing.